COMMUNIQUÉS West-GlobeNewswire

BrainStorm Announces Second Clinical Site to Enroll Patients in Its Progressive MS Phase 2 Study
30/05/2019
NEW YORK, May 30, 2019 (GLOBE NEWSWIRE) -- BrainStorm Cell Therapeutics Inc. ( NASDAQ: BCLI ), a leader in developing innovative autologous cellular therapies for highly debilitating neurodegenerative diseases, today [...]
Mesoblast Initiates Rolling Submission of Biologics License Application (BLA) to U.S. FDA for remestemcel-L in the Treatment of Acute Graft Versus Host Disease
30/05/2019
MELBOURNE, Australia and NEW YORK, May 29, 2019 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in cellular medicines for inflammatory diseases, today announced that it has filed the first [...]
Helix BioPharma Corp. Closes Private Placement
30/05/2019
RICHMOND HILL, Ontario, May 29, 2019 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: “HBP”) (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the prevention and treatment [...]
Indus Holdings, Inc. Reports Record Revenue in the First Quarter 2019 Financial Results
30/05/2019
Indus reports revenue of $6.4 million, representing 180% revenue growth year over year SALINAS, Calif., May 29, 2019 (GLOBE NEWSWIRE) -- Indus Holdings, Inc. ("Indus") (CSE:INDS), a leading, vertically integrated [...]
Eve & Co Announces Second German Supply Agreement; Provides Update on First German Supply Agreement
29/05/2019
TORONTO, May 29, 2019 (GLOBE NEWSWIRE) -- Eve & Co Incorporated (the “Company” or “Eve & Co”) (TSXV: EVE; OTCQB: EEVVF) is pleased to announce that its wholly-owned subsidiary Natural MedCo Ltd. has entered into [...]
GILEAD AND GALAPAGOS TO PRESENT LATEST DATA ON FILGOTINIB AT THE ANNUAL EUROPEAN CONGRESS OF RHEUMATOLOGY (EULAR 2019)
29/05/2019
-- Phase 3 FINCH 1 and FINCH 3 Data of Filgotinib in Rheumatoid Arthritis to Be Featured in Opening Plenary and Late Breaker Sessions -- Foster City, Calif. and Mechelen, Belgium; May 29, 2019; 22.30 CET - Gilead [...]
electroCore Announces Comprehensive Redeployment and Cost Reduction Plan
29/05/2019
Management to host conference call and webcast at 8:30am ET on Thursday, May 30 BASKING RIDGE, N.J., May 29, 2019 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, [...]
Aptose Announces Proposed Public Offering of Common Shares
29/05/2019
SAN DIEGO and TORONTO, May 29, 2019 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), today announced that it has commenced an underwritten public offering of its Common [...]
Xenon Pharmaceuticals to Present at the Jefferies 2019 Healthcare Conference
29/05/2019
BURNABY, British Columbia, May 29, 2019 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a clinical-stage biopharmaceutical company, today announced that Dr. Simon Pimstone, Xenon's Chief Executive Officer [...]
Myovant Sciences Announces $100 Million Public Offering of Common Shares
29/05/2019
BRISBANE, Calif. and BASEL, Switzerland, May 29, 2019 (GLOBE NEWSWIRE) -- Myovant Sciences (NYSE: MYOV) (“ Myovant ”), a clinical-stage healthcare company focused on developing and commercializing innovative therapies [...]
Supernus to Present at the Jefferies 2019 Global Healthcare Conference
29/05/2019
ROCKVILLE, Md., May 29, 2019 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system [...]
Kane Biotech to Showcase Technologies and Products at the 2019 BIO International Convention
29/05/2019
WINNIPEG, Manitoba, May 29, 2019 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE), (the “Corporation” or “Kane Biotech”), a biotechnology company engaged in the research, development and commercialization of [...]
Amicus Therapeutics Announces Public Offering of Common Stock
29/05/2019
CRANBURY, N.J., May 29, 2019 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced it has commenced a $150 million underwritten public offering of its common stock. J.P. Morgan Securities LLC, Goldman [...]
BioDelivery Sciences Announces Upcoming Investor Conference Presentations
29/05/2019
RALEIGH, N.C., May 29, 2019 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing commercial-stage specialty pharmaceutical company dedicated to patients living with chronic [...]
Synthorx to Present at Jefferies 2019 Healthcare Conference
29/05/2019
SAN DIEGO, May 29, 2019 (GLOBE NEWSWIRE) -- Synthorx, Inc. (NASDAQ: THOR), a biotechnology company using a first-of-its-kind Expanded Genetic Alphabet platform technology to discover and develop optimized biologics for [...]
Bellicum Pharmaceuticals to Present at Jefferies 2019 Healthcare Conference
29/05/2019
HOUSTON, May 29, 2019 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM) , a leader in developing novel, controllable cellular immunotherapies for cancers and orphan inherited blood disorders, today [...]
Guardant Health to Present at the William Blair 2019 Growth Stock Conference
29/05/2019
REDWOOD CITY, Calif., May 29, 2019 (GLOBE NEWSWIRE) -- Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast [...]
Kiniksa Pharmaceuticals to Present at Upcoming Investor Conferences
29/05/2019
HAMILTON, Bermuda, May 29, 2019 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) announced today that it will present at the following investor conferences in June: Jefferies 2019 Global Healthcare [...]
Trevena to Participate in Upcoming Conferences in June 2019
29/05/2019
CHESTERBROOK, Pa., May 29, 2019 (GLOBE NEWSWIRE) -- Trevena, Inc. (Nasdaq: TRVN) , a biopharmaceutical company focused on the development and commercialization of novel medicines for patients affected by Central Nervous [...]

Pages